{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP03632",
    "Peptide Name": "Clovibactin (Leu-rich; natural AMPs; nonribosomal peptide, Gram-negative bacteria, prokaryotes, depsipeptide, lactone, XXJ, XXK, XXD2; UCSB1b; BBW)",
    "Source": "Eleftheria terraessp. carolina",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "FLKSNALL",
    "Sequence Length": 8,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Anti-MRSA"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Beta",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 2,
    "Boman Index": -0.49,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "63%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Discovery: isolated from unculltured soil bacteria.Sequence analysis: APD analysis reveals this sequence is most similar (50%) toTemporin-RaL: 38%.Chemical modification: Leu2 and Lys3 are D-amino acids (XXD), Asn5 is beta-hydroxylated (XXK), the hydroxyl group of Asn5 forms an ester bond with the carboxyl group of C-terminal Leu8 (XXJ).Activity: Active against primarily Gram-positive pathogens, S. aureus susceptible and resistant strains NCTC 8325 NRS108 NRS71 MRSA Mu50 VISA (MIC 0.125-2 ug/ml), S. epidermidis ATCC 35982 or NRS8 (MIC 0.5 ug/ml), S. haemolyticus NRS9 or NRS69 (MIC 0.5-1 ug/ml), E. faecium BM4147 VRE (MIC 0.5-2 ug/ml), anti-VRE, B. subtilis 1A1 or 168 (MIC 1-2 ug/ml), B. anthracis Sterne (MIC 0.25 ug/ml), S. pneumoniae ATCC10813 (MIC 0.25-0.5 ug/ml), S. pyogenes ATCC19615 (MIC 0.25-0.5 ug/ml), S. warneri NRS138 (MIC 1 ug/ml), M. smegmatis MC2 155 (MIC 2 ug/ml), M. tuberculosis MC2 6020 (MIC 0.5-1 ug/ml), Gram- H. influenzae SJ7 (MIC 2 ug/ml), E. coli K12 (MIC 64 ug/ml), and P.aeruginosa PA-01 (MIC >128 ug/ml).MOA:bacteria: Peptide can oligomerize into supramolecular fibrils due to a beta-sheet peptide structure upon contact with target. Clovibactin blocks cell wall synthesis by targeting pyrophosphate of multiple essential peptidoglycan precursors (C55PP, Lipid II, LipidWTA).Resistance development:no:bacteria:S. aureus: resistance frequency <10power-10. multiple targets explain lack of resistance. More data needed. Provided by Nongnuj Tanphaichitr.Updated 7/2024",
    "Author": "Shukla R, Peoples AJ, Ludwig KC, Maity S, Derks MGN, De Benedetti S, Krueger AM, Vermeulen BJA, Harbig T, Lavore F, Kumar R, Honorato RV, Grein F, Nieselt K, Liu Y, Bonvin AMJJ, Baldus M, Kubitscheck U, Breukink E, Achorn C, Nitti A, Schwalen CJ, Spoering AL, Ling LL, Hughes D, Lelli M, Roos WH, Lewis K, Schneider T, Weingarth M. 2023",
    "Reference": "Cell. 2023 Sep 14;186(19):4059-4073.e27. doi: 10.1016/j.cell.2023.07.038.Pub-Med.",
    "Title": "An antibiotic from an uncultured bacterium binds to an immutable target."
  },
  "3D Structure": []
}